Literature DB >> 29857294

Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury.

Baochen Zhu1, Wantong Zhang2, Yang Lu1, Shaonan Hu1, Rui Gao2, Zongxi Sun1, Xiaonan Chen1, Junming Ma1, Shuang Guo1, Shouying Du3, Pengyue Li4.   

Abstract

BACKGROUND & AIMS: Aspirin is the first line therapy for cardiovascular and cerebrovascular diseases and is widely used. However aspirin-induced gastrointestinal injury is one of its most common side effect which limits long-term use. Panax Notoginseng Saponins(PNS) which is also used to prevent thrombus may alleviate this side effect according to previous clinical evidences. Owing to the complexity of drug combination, the protective mechanism of PNS on aspirin-induced gastrointestinal injury remains unclear. Therefore, a network pharmacology-based strategy was proposed in this study to address this problem.
METHODS: A network pharmacology approach comprising multiple components, candidate targets of each component, known therapeutic targets, network analysis has been used in this study. Also, we establish aspirin-induced gastrointestinal injury model by the oral administration of aspirin (0.5 g/kg body weight) to verify the predicted targets from network pharmacology. All rats was randomly allocated to control groups (n = 6),aspirin groups (n = 6)and aspirin + PNS groups (n = 6) and conducted H&E staining and ELISA for VEGFA.
RESULTS: The comprehensive systematic approach was successfully to identify 5 compounds and 154 candidate targets in PNS and 479 candidate targets in aspirin. After network establishment and analysis, 27 potential targets hit by PNS, aspirin and 6 kind of gastrointestinal diseases were found. The experiments results indicated that aspirin group has visible inflammation and lesions while aspirin + PNS group have not. The higher expression of VEGFA in aspirin + PNS group verified the predicted potential protective targets of PNS.
CONCLUSIONS: PNS may have protective function for aspirin-induced gastrointestinal injury through increasing VEGFA expression. Network pharmacology strategy may provide a forceful tool for exploring the mechanism of herb medicine and discovering novel bioactive ingredients.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Aspirin; Gastrointestinal injury; Network pharmacology; Panax Notoginseng Saponins(PNS)

Mesh:

Substances:

Year:  2018        PMID: 29857294     DOI: 10.1016/j.biopha.2018.04.054

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.

Authors:  Wei Hang; Hui-Jie Fan; Yan-Rong Li; Qi Xiao; Lu Jia; Li-Juan Song; Yao Gao; Xiao-Ming Jin; Bao-Guo Xiao; Jie-Zhong Yu; Cun-Gen Ma; Zhi Chai
Journal:  Metab Brain Dis       Date:  2022-04-30       Impact factor: 3.584

2.  Exploring the mechanism of Jianpi Qushi Huayu Formula in the treatment of chronic glomerulonephritis based on network pharmacology.

Authors:  Tao Liu; Ya Chen Gao; Xiu Juan Qin; Jia Rong Gao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-10-07       Impact factor: 3.000

3.  Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach.

Authors:  Yujie Zhang; Xiaolin Zhang; Xi Zhang; Yi Cai; Minghui Cheng; Chenghui Yan; Yaling Han
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-07       Impact factor: 2.629

4.  Dissecting the mechanism of Yuzhi Zhixue granule on ovulatory dysfunctional uterine bleeding by network pharmacology and molecular docking.

Authors:  Jialin Li; Hua Luo; Xinkui Liu; Jingyuan Zhang; Wei Zhou; Siyu Guo; Xiuping Chen; Yingying Liu; Shanshan Jia; Haojia Wang; Bingbing Li; Guoliang Cheng; Jiarui Wu
Journal:  Chin Med       Date:  2020-10-23       Impact factor: 5.455

5.  Investigation of the Lipid-Lowering Mechanisms and Active Ingredients of Danhe Granule on Hyperlipidemia Based on Systems Pharmacology.

Authors:  Kuikui Chen; Zhaochen Ma; Xiaoning Yan; Jie Liu; Wenjuan Xu; Yueting Li; Yihang Dai; Yinhuan Zhang; Hongbin Xiao
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

6.  Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer.

Authors:  Tan Li; Zhu Baochen; Zhang Yue; Wang Cheng; Wu Yali; Sun Zongxi; Zhang Wantong; Lu Yang; Du Shouying
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis.

Authors:  Dan Wang; Ruisheng Li; Shizhang Wei; Sijia Gao; Zhuo Xu; Honghong Liu; Ruilin Wang; Haotian Li; Huadan Cai; Jian Wang; Yanling Zhao
Journal:  Chin Med       Date:  2019-08-28       Impact factor: 5.455

8.  Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Authors:  Ming-Fei Guo; Ya-Ji Dai; Jia-Rong Gao; Pei-Jie Chen
Journal:  J Diabetes Res       Date:  2020-03-02       Impact factor: 4.011

9.  Pharmacological Effects of Agastache rugosa against Gastritis Using a Network Pharmacology Approach.

Authors:  Hyeon-Hwa Nam; Joong Sun Kim; Jun Lee; Young Hye Seo; Hyo Seon Kim; Seung Mok Ryu; Goya Choi; Byeong Cheol Moon; A Yeong Lee
Journal:  Biomolecules       Date:  2020-09-09

10.  Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial.

Authors:  Bao-Chen Zhu; Chun-Miao Xue; Rui Lang; Wei-Liang Weng; Xu-Jie Wang; Zhen-Zhen Lei; Sha-Sha Zhang; Wen-Hua Yang; Wan-Tong Zhang; Guo-Dong Hua
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.